Anzeige
Mehr »
Montag, 16.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
697 Leser
Artikel bewerten:
(2)

Delisting of Securities of Puhui Wealth Investment Management Co., Ltd.; National Energy Services Reunited Corp.; Bed Bath & Beyond Inc.; IMV Inc.; Celyad Oncology SA; Aptinyx Inc.; Athenex, Inc.; Greencity Acquisition; QualTek Services and others

NEW YORK, July 06, 2023 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the ordinary shares of Puhui Wealth Investment Management Co., Ltd. Puhui Wealth Investment Management Co., Ltd.'s securities were suspended on March 29, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the ordinary shares and warrant of National Energy Services Reunited Corp. National Energy Services Reunited Corp.'s securities were suspended on April 28, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Bed Bath & Beyond Inc. Bed Bath & Beyond Inc.'s securities were suspended on May 3, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common shares of IMV Inc. IMV Inc.'s securities were suspended on May 11, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the American depositary shares of Celyad Oncology SA. Celyad Oncology SA's securities were suspended on May 19, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Aptinyx Inc. Aptinyx Inc.'s securities were suspended on May 19, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Athenex, Inc. Athenex, Inc.'s securities were suspended on April 13, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the ordinary shares, unit, and warrants of Greencity Acquisition Corporation. Greencity Acquisition Corporation's securities were suspended on June 1, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock and warrant of QualTek Services Inc. QualTek Services Inc.'s securities were suspended on June 2, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Bellicum Pharmaceuticals, Inc. Bellicum Pharmaceuticals, Inc.'s securities were suspended on June 2, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common shares and warrant of Wejo Group Limited. Wejo Group Limited's securities were suspended on June 9, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the Class A common stock of Cyxtera Technologies, Inc. Cyxtera Technologies, Inc.'s securities were suspended on June 15, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of HTG Molecular Diagnostics, Inc. HTG Molecular Diagnostics, Inc.'s securities were suspended on June 15, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Unico American Corporation. Unico American Corporation's securities were suspended on June 15, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of PolarityTE, Inc. PolarityTE, Inc.'s securities were suspended on June 16, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Oncorus, Inc. Oncorus, Inc.'s securities were suspended on June 21, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of OncoSec Medical Incorporated. OncoSec Medical Incorporated's securities were suspended on June 26, 2023, and have not traded on Nasdaq since that time.

For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com. Nasdaq's rules governing the delisting of securities can be found in the Nasdaq Rule 5800 Series, available on the Nasdaq Web site: https://listingcenter.nasdaq.com/rulebook/nasdaq/rules/nasdaq-5800-series.


© 2023 GlobeNewswire (Europe)
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.